CENTOGENE N V's ticker is CNTG and the CUSIP is N1976T109. A total of 15 filers reported holding CENTOGENE N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -25.0% | 13 | 0.0% | 0.00% | – |
| Q2 2023 | $20 | -98.0% | 13 | -98.5% | 0.00% | – |
| Q1 2023 | $1,000 | +99900.0% | 871 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 871 | +61.6% | 0.00% | – |
| Q3 2022 | $1,000 | – | 539 | +4046.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 13 | -94.7% | 0.00% | – |
| Q1 2022 | $1,000 | -97.3% | 245 | -96.6% | 0.00% | – |
| Q4 2021 | $37,000 | +428.6% | 7,289 | +1026.6% | 0.00% | – |
| Q3 2021 | $7,000 | – | 647 | +1802.9% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 34 | -99.9% | 0.00% | – |
| Q1 2021 | $279,000 | +18.2% | 22,996 | +5.3% | 0.00% | – |
| Q4 2020 | $236,000 | +306.9% | 21,845 | +258.9% | 0.00% | – |
| Q3 2020 | $58,000 | -14.7% | 6,087 | +103.9% | 0.00% | – |
| Q2 2020 | $68,000 | +11.5% | 2,985 | -2.3% | 0.00% | – |
| Q1 2020 | $61,000 | +144.0% | 3,054 | +23.7% | 0.00% | – |
| Q4 2019 | $25,000 | – | 2,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 409,388 | $4,413,000 | 0.10% |
| Walleye Capital LLC | 86,582 | $933,000 | 0.06% |
| Granahan Investment Management | 154,387 | $1,664,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 200,000 | $2,156,000 | 0.02% |
| FEDERATED HERMES, INC. | 324,939 | $3,503,000 | 0.01% |
| Alyeska Investment Group, L.P. | 33,441 | $360,000 | 0.01% |
| Pentwater Capital Management LP | 16,784 | $181,000 | 0.00% |
| Squarepoint Ops LLC | 22,306 | $240,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,601 | $18,000 | 0.00% |
| Laurion Capital Management LP | 15,166 | $163,000 | 0.00% |